From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids
Ruediger Nave, Helgert Mueller Nycomed: a Takeda Company, Nycomed GmbH, Konstanz, Germany Abstract: Asthma continues to be a global health problem and currently available treatments such as corticosteroids can cause unwanted side effects. Inhaled corticosteroids (ICS) are recommended as first-line t...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-03-01
|
| Series: | International Journal of General Medicine |
| Online Access: | http://www.dovepress.com/from-inhaler-to-lung-clinical-implications-of-the-formulations-of-cicl-a12401 |